{"altmetric_id":24221618,"selected_quotes":["New cancer clinical trial: Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Stage III-IVB \u2026"],"citation":{"altmetric_jid":"clinicaltrialsgov","authors":["National Cancer Institute (NCI)"],"first_seen_on":"2017-08-23T12:50:00+00:00","issns":[],"journal":"ClinicalTrials.gov","last_mentioned_on":1503499553,"links":["https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03258554?term=cancer&lup_s=08\/09\/2017&lup_d=14&show_rss=Y&sel_rss=mod14","https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03258554?term=HEAD%20AND%20NECK&recrs=abc&lup_s=08%2F09%2F2017&lup_d=14&show_rss=Y&sel_rss=mod14"],"nct_id":"NCT03258554","pubdate":"2017-08-22T00:00:00+00:00","publisher":"ClinicalTrials.gov","title":"Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Stage III-IVB Head and Neck Cancer Who Cannot Take Cisplatin","type":"clinical_trial_study_record"},"altmetric_score":{"score":1.75,"score_history":{"1y":1.75,"6m":1.75,"3m":1.75,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":1.75},"context_for_score":{"all":{"total_number_of_other_articles":8418826,"mean":7.0849522326371,"rank":3878716,"this_scored_higher_than_pct":52,"this_scored_higher_than":4455765,"rank_type":"exact","sample_size":8418826,"percentile":52},"similar_age_3m":{"total_number_of_other_articles":169964,"mean":12.72461828751,"rank":72855,"this_scored_higher_than_pct":55,"this_scored_higher_than":94208,"rank_type":"exact","sample_size":169964,"percentile":55},"this_journal":{"total_number_of_other_articles":24831,"mean":10.521629963753,"rank":10356,"this_scored_higher_than_pct":57,"this_scored_higher_than":14181,"rank_type":"exact","sample_size":24831,"percentile":57},"similar_age_this_journal_3m":{"total_number_of_other_articles":877,"mean":2.7228652968037,"rank":102,"this_scored_higher_than_pct":83,"this_scored_higher_than":730,"rank_type":"exact","sample_size":877,"percentile":83}}},"demographics":{"poster_types":{"member_of_the_public":3},"users":{"twitter":{"cohorts":{"Members of the public":3}}},"geo":{"twitter":{"IN":1,"US":1}}},"counts":{"total":{"posts_count":4},"twitter":{"unique_users_count":3,"unique_users":["xeroxnet69","JROSENBERG1","DonJohnstonLC"],"posts_count":3},"googleplus":{"unique_users_count":1,"unique_users":["Alexandros G. Sfakianakis"],"posts_count":1}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/xeroxnet69\/statuses\/900339283059462144","license":"gnip","citation_ids":[24221618],"posted_on":"2017-08-23T12:49:47+00:00","author":{"name":"\u4e02\u03b1\u0399\u03b9\u039c \u03b1\u0399\u03b9","image":"https:\/\/pbs.twimg.com\/profile_images\/900546423539736576\/vZvnPZTQ_normal.jpg","description":"An Android Enthusiasts from Assam, IN he loves to Explore-Gain-Share Technology news and Interact with people.\nInstagram : @imsalimali","id_on_source":"xeroxnet69","tweeter_id":"779945586409762817","geo":{"lt":20,"ln":77,"country":"IN"},"followers":27},"tweet_id":"900339283059462144"},{"url":"http:\/\/twitter.com\/JROSENBERG1\/statuses\/900339990030200833","license":"gnip","citation_ids":[24221618],"posted_on":"2017-08-23T12:52:35+00:00","author":{"name":"JROSENBERG","url":"http:\/\/www.thebiggestnews.com","image":"https:\/\/pbs.twimg.com\/profile_images\/878105235683774472\/hhC8B7WO_normal.jpg","description":"http:\/\/THEBIGGESTNEWS.COM \nThe Biggest News Ever!","id_on_source":"JROSENBERG1","tweeter_id":"20725212","geo":{"lt":null,"ln":null},"followers":1634},"tweet_id":"900339990030200833"},{"url":"http:\/\/twitter.com\/DonJohnstonLC\/statuses\/900346089068523520","license":"gnip","citation_ids":[24221618],"posted_on":"2017-08-23T13:16:49+00:00","author":{"name":"Don Johnston (LC)","url":"https:\/\/LimaCharlieNews.com","image":"https:\/\/pbs.twimg.com\/profile_images\/899843960767643648\/x30pTAZ9_normal.jpg","description":"Don Johnston | Co-Founder @LimaCharlieNews                             Entrepreneur | U.S. Army Combat Veteran           \nNonpartisan | Your Feelings \u2260 Reality","id_on_source":"DonJohnstonLC","tweeter_id":"736680450580721664","geo":{"lt":43.00035,"ln":-75.4999,"country":"US"},"followers":2688},"tweet_id":"900346089068523520"}],"googleplus":[{"title":"Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Stage III-IVB Head and Neck...","url":"https:\/\/plus.google.com\/111155740652386324332\/posts\/dvVhc62wDqL","license":"public","citation_ids":[24221618],"posted_on":"2017-08-23T14:45:53+00:00","summary":"Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Stage III-IVB Head and Neck... Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Stage III-IVB Head and Neck Cancer Who Cannot Take Cisplatin Radiation Therapy","author":{"name":"Alexandros G. Sfakianakis","url":"https:\/\/plus.google.com\/+AlexandrosGSfakianakisEarsNoseThroatMedicine","image":"https:\/\/lh6.googleusercontent.com\/-lZLgZSSNnmY\/AAAAAAAAAAI\/AAAAAAAAABk\/bkJJCRNiVoo\/photo.jpg?sz=50","id_on_source":"111155740652386324332"}}]}}